Survival of patients with kidney cancer in central and northern Denmark, 1998–2009

Figures & data

Figure 1 Age distribution at the time of diagnosis for men and women with kidney cancer in the period 1998–2009 in the central and the northern Denmark regions.

Figure 2 Overall survival of Danish kidney cancer patients diagnosed in the period 1998–2009 in the central and the northern Denmark regions.

Table 1 One-, 3-, and 5-year crude cumulative survival and gender- and age-adjusted all-cause MRRs in Danish kidney cancer patients, 1998–2009

	Year of diagnosis
	1998–2000	2001–2003	2004–2006	2007–2009
Number of cancer patients	583	571	652	853
Median age (years)	69	69	69	68
1 year
Survival	56% (52%–60%)	60% (56%–64%)	62% (59%–66%)	63% (60%–67%)
MRR	1(reference)	0.87 (0.73–1.04)	0.82 (0.69–0.98)	0.79 (0.67–0.94)
Adjusted MRRa	1(reference)	0.90 (0.75–1.07)	0.84 (0.70–1.00)	0.78 (0.66–0.93)
3 year
Survival	40% (36%–44%)	45% (41%–49%)	50% (47%–54%)	51% (47%–54%)b
MRR	1(reference)	0.88 (0.75–1.02)	0.78 (0.67–0.91)	0.77 (0.66–0.88)b
Adjusted MRRa	1(reference)	0.90 (0.77–1.05)	0.78 (0.67–0.91)	0.76 (0.66–0.87)b
5 year
Survival	33% (29%–37%)	37% (33%–41%)	41% (38%–45%)b	42% (38%–45%)b
Relative MRR	1(reference)	0.89 (0.77–1.02)	0.80 (0.69–0.92)b	0.79 (0.69–0.90)b
Adjusted MRRa	1(reference)	0.91 (0.79–1.05)	0.80 (0.70–0.92)b	0.77 (0.68–0.89)b

Notes: The corresponding 95% confidence intervals are given in parentheses;

a adjusted for age and gender;

b predicted values.

Abbreviation: MRR, mortality rate ratio.

Table 2 One-, 3-, and 5-year survival and MRRs in Danish men with kidney cancer, 1998–2009, stratified by age group

Men Age (years)	Year of diagnosis
	1998–2000	2001–2003	2004–2006	2007–2009
15–59
Number of cancer patients	99	117	131	148
1-year survival	76% (66%–83%)	72% (63%–79%)	78% (70%–84%)	69% (60%–76%)
3-year survival	62% (51%–70%)	57% (48%–66%)	66% (57%–73%)	59% (50%–66%)a
5-year survival	55% (44%–64%)	54% (44%–62%)	60% (51%–67%)a	53% (45%–61%)a
60–74
Number of cancer patients	136	137	159	226
1-year survival	57% (48%–64%)	66% (57%–73%)	64% (56%–71%)	67% (60%–73%)
3-year survival	45% (36%–53%)	48% (39%–56%)	55% (47%–63%)	54% (47%–61%)a
5-year survival	35% (27%–43%)	35% (27%–43%)	42% (34%–50%)a	41% (34%–48%)a
75+
Number of cancer patients	100	86	102	138
1-year survival	43% (33%–52%)	51% (40%–61%)	43% (33%–52%)	47% (38%–55%)
3-year survival	26% (18%–35%)	36% (26%–46%)	31% (23%–40%)	36% (28%–45%)a
5-year survival	18% (11%–26%)	26% (17%–35%)	22% (14%–30%)a	24% (17%–33%)a

Notes: The corresponding 95% confidence intervals are given in parentheses;

a predicted values.

Abbreviation: MRR, mortality rate ratio.

Table 3 One-, 3-, and 5-year survival and MRRs in Danish women with kidney cancer, 1998–2009, stratified by age group

Women Age (years)	Year of diagnosis
	1998–2000	2001–2003	2004–2006	2007–2009
15–59
Number of cancer patients	51	54	52	71
1-year survival	75% (60%–84%)	72% (58%–82%)	65% (51%–77%)	77% (65%–85%)
3-year survival	49% (35%–62%)	63% (49%–74%)	58% (43%–70%)	68% (54%–78%)a
5-year survival	41% (28%–54%)	54% (40%–66%)	54% (40%–66%)a	63% (49%–74%)a
60–74
Number of cancer patients	116	108	118	146
1-year survival	59% (49%–67%)	58% (48%–67%)	65% (56%–73%)	74% (66%–81%)
3-year survival	41% (32%–50%)	39% (30%–48%)	52% (42%–60%)	58% (49%–66%)a
5-year survival	34% (26%–43%)	32% (24%–41%)	44% (35%–52%)a	49% (40%–58%)a
75+
Number of cancer patients	81	69	90	124
1-year survival	33% (23%–44%)	35% (24%–46%)	53% (43%–63%)	49% (40%–57%)
3-year survival	19% (11%–28%)	26% (16%–37%)	36% (26%–45%)	33% (25%–41%)a
5-year survival	12% (6%–20%)	20% (12%–30%)	25% (16%–34%)a	23% (16%–31%)a

Notes: The corresponding 95% confidence intervals are given in parentheses;

a predicted values.

Abbreviation: MRR, mortality rate ratio.

Table 4 Thirty-day mortality and MRR after nephrectomy in Danish patients with kidney cancer, 1998–2009

	Year of surgery
	1998–2000	2001–2003	2004–2006	2007–2009
Number of cancer patients	282	309	330	411
Median age (years)	67	66	64	65
30-day mortality	3.5% (1.9%–6.5%)	2.3% (1.1%–4.7%)	2.7% (1.4%–5.2%)	2.2% (1.1%–4.2%)
30-day MRR	1(reference)	0.63 (0.24–1.66)	0.77 (0.31–1.89)	0.61 (0.25–1.51)
30-day MRRa	1(reference)	0.66 (0.25–1.72)	0.81 (0.33–1.99)	0.62 (0.25–1.52)

Notes: The corresponding 95% confidence intervals are given in parentheses;

a adjusted for age and gender.

Abbreviation: MRR, mortality rate ratio.